NextGen Healthcare Releases Significant Product Enhancements to its EHR-agnostic Mobile Suite, Including Support for Inpatien...
November 16 2017 - 7:30AM
Business Wire
Quality Systems, Inc. (NASDAQ: QSII), known to its clients as
NextGen Healthcare, today announced significant product
enhancements to its mobile workflow solution, including new
functionality that enables physicians to utilize speech-driven
documentation support in both clinic and hospital settings and
facilitates the management of ICD-10 diagnoses to accelerate
billing. The new functionality drives time savings for caregivers
by increasing workflow efficiency, improving access to patient
information and streamlining common clinic and administrative
tasks.
This press release features multimedia. View
the full release here:
http://www.businesswire.com/news/home/20171116005714/en/
NextGen Healthcare's mobile suite helps
providers across the continuum of care regain time so they can
focus on what matters most, delivering exceptional patient care.
(Photo: Business Wire)
This platform upgrade is the first major product enhancement
from Entrada following its acquisition by NextGen Healthcare,
earlier this year.
Providers often work from multiple care settings – including
outpatient clinics, surgery centers and hospitals – each with
unique workflows and charting requirements. NextGen Mobile Suite
now provides clinical documentation support specifically for the
hospital setting, enabling providers to switch between inpatient
and outpatient use cases from within a single mobile interface.
With real-time access to the hospital census list, providers can
use speech-driven documentation options (speech-to-text,
transcription and remote scribe) to capture robust patient notes at
the point-of-care during hospital rounds.
In addition to inpatient support, NextGen Mobile Suite now
provides mobile access to the industry-leading IMO Problem IT
Terminology diagnosis entry tool, powered by Intelligent Medical
Objects, Inc. (IMO). The tool is embedded directly inside the
platform, allowing users to expedite and simplify entering
diagnosis codes into their EHRs. The tool, with more than 800,000
unique clinical concepts and 1.8+ million synonyms, ensures the
accurate capture of physicians’ narrative and integration with EHR
terminology.
Other new product enhancements allow providers to:
- Enable physicians to electronically
sign documents from the mobile device.
- Annotate on clinical images captured
from Entrada prior to sending to the EHR.
- Utilize fast and secure finger-print
login on physicians’ mobile devices.
“Industry dynamics are requiring physicians to be proficient in
technology across multiple systems, devices and care settings. Our
goal is simple – to provide easy-to-use solutions that allow
clinicians to remain focused on delivering quality patient care and
practice meaningful medicine,” said Rusty Frantz, President and CEO
of NextGen Healthcare. “With these new enhancements, our platform
allows physicians, and their entire care team, to remain productive
by reducing the administrative burden, ultimately enabling better
workflow management across systems, both in the ambulatory and
inpatient setting alike.”
SAFE HARBOR PROVISIONS FOR FORWARD-LOOKING STATEMENTS
This news release may contain forward-looking statements within
the meaning of the federal securities laws, including but not
limited to, statements made by Rusty Frantz, President and
CEO, statements regarding enhancements to the Company’s Entrada
product, and other statements regarding future events, developments
in the Company’s business and in the overall healthcare sector, the
Company's future performance, as well as management's expectations,
beliefs, intentions, plans, estimates or projections relating to
the future. The Company cautions investors not to place undue
reliance on any such forward-looking statements, which are based on
information available at the time those statements are made or
management's good faith belief as of that time with regard to
future events, and should not be read as a guarantee of future
performance or results. Risks and uncertainties exist that may
cause the results to differ materially from those set forth in
these forward-looking statements. Factors that could cause the
anticipated results to differ from those described in the
forward-looking statements and additional risks and uncertainties
are set forth in Part I, Item A of our most recent Annual Report on
Form 10-K and subsequently filed Quarterly Reports on Form 10-Q,
including but not limited to: the volume and timing of systems
sales and installations; length of sales cycles and the
installation process; the possibility that products will not
achieve or sustain market acceptance; seasonal patterns of sales
and customer buying behavior; impact of incentive payments under
The American Recovery and Reinvestment Act on sales and the ability
of the Company to meet continued certification requirements; the
development by competitors of new or superior technologies; the
timing, cost and success or failure of new product and service
introductions, development and product upgrade releases; undetected
errors or bugs in software; product liability; changing economic,
political or regulatory influences in the health-care industry;
changes in product-pricing policies; availability of third-party
products and components; competitive pressures including product
offerings, pricing and promotional activities; the Company's
ability or inability to attract and retain qualified personnel;
possible regulation of the Company's software by the U.S. Food
and Drug Administration; changes of accounting estimates and
assumptions used to prepare the prior periods' financial
statements; disruptions caused by acquisitions of companies,
products, or technologies; and general economic
conditions. These forward-looking statements speak only as of
the date hereof. The Company undertakes no obligation to publicly
update any forward-looking statements, whether as a result of new
information, future events or otherwise.
About Quality Systems, Inc.
Quality Systems, Inc., known to its clients as NextGen
Healthcare, provides a range of software, services, and analytic
solutions to medical and dental group practices. The Company’s
portfolio delivers foundational capabilities to empower physician
success, enrich the patient care experience and enable the
transition to value-based healthcare. Visit www.qsii.com and
www.nextgen.com for additional information.
About Intelligent Medical Objects, Inc. (IMO)
Intelligent Medical Objects, Inc. (IMO), is the developer of the
most widely-accepted medical terminology solution for the
management of medical vocabularies and software applications at
healthcare organizations worldwide. IMO’s terminology is used by
more than 3,500 hospitals and 450,000 physicians daily, and this
trusted terminology platform supports innovations by provider
systems. IMO medical vocabulary and mapping products effectively
capture clinical intent and help EMRs preserve and communicate this
across the entire spectrum of care. IMO clinical terms are mapped
to all standard coding systems including ICD-9, ICD-10, and
SNOMED®. The accuracy of IMO’s interface terminology was found to
be “nearly perfect” in an independent study published by the US
Centers for Disease Control. Visit www.e-imo.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171116005714/en/
For Media and Public Relations Inquiries:Finn
Partners:Agata Porter, (212)
715-1595agata.porter@finnpartners.com
Quality Systems (NASDAQ:QSII)
Historical Stock Chart
From Aug 2024 to Sep 2024
Quality Systems (NASDAQ:QSII)
Historical Stock Chart
From Sep 2023 to Sep 2024